Mutations in the ACVR1 gene encoding for ALK2 occur in 25–33 ​% of patients with the rare pediatric cancer diffuse intrinsic pontine glioma (DIPG), with many being gain-of-function over-activating mutations [[52], [53], [54]]. The gene discussed is ACVR1; the disease is childhood malignant neoplasm.